SP Bioscience LLP (SPB) is operational since August 2018 in the healthcare sector. SPB primarily focuses on-Site Management Activities for Phase II to IV trials for drugs and devices in Cardiovascular, Endocrinology and Metabolic, Infectious Diseases (Blinded as well as Unblinded set-up), Respiratory, Urology, Dermatology, Orthopedics and Oncology department.

SPB also operates in other healthcare segments such as marketing and distribution of surgical equipment and medicines, medical training, etc.